Since the glutaminolytic pathway appears critical in the reprogramming of tumor cell metabolism to satisfy the increased energy needs of these cells, our results create a novel opportunity for modulating the glutaminolytic pathway by acting on the ERK5 route. The gene discussed is MAPK7; the disease is neoplasm.